Gender differences and management of stroke risk of nonvalvular atrial fibrillation in an upper middle-income country: Insights from the CARMEN-AF registry

Friberg, 2013, Atrial fibrillation prevalence revisited, J. Intern. Med., 10.1111/joim.12114 Heeringa, 2006, Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, Eur. Heart J., 10.1093/eurheartj/ehi825 Lloyd-Jones, 2004, Lifetime risk for development of atrial fibrillation: the Framingham heart study, Circulation, 10.1161/01.CIR.0000140263.20897.42 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation, Chest, 10.1378/chest.09-1584 Mazurek, 2018, Gender differences in antithrombotic treatment for newly diagnosed atrial fibrillation: the GLORIA-AF registry program, Am. J. Med., 131, 945, 10.1016/j.amjmed.2018.03.024 González-Hermosillo, 2017, Design of an atrial fibrillation and embolic risk registry in Mexico: CARMEN-AF, Arch. Cardiol. Mex., 87, 5 World Bank, 2017 Lip, 2015, Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: the prospective global anticoagulant registry in the FIELD-Atrial Fibrillation, Circ. Cardiovasc. Qual. Outcomes, 10.1161/CIRCOUTCOMES.114.001556 Lee, 2018, Gender-related differences in management of nonvalvular atrial fibrillation in an Asian population, Korean Circ. J. Kirchhof, 2016, 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur. Heart J., 10.1093/eurheartj/ehw210 John Camm, 2012, 2012 focused update of the ESC guidelines for the management of atrial fibrillation, Eur. Heart J., 2719 Gillis, 2017, Atrial fibrillation and ventricular arrhythmias: sex differences in electrophysiology, epidemiology, clinical presentation, and clinical outcomes, Circulation, 10.1161/CIRCULATIONAHA.116.025312